Latest / Bloomberg Law / Bloomberg Law Brief: IRS Probe into Tax-Exempt Charity (Audio)
Transcript
- 0:00Speaker 1: Well, now is time for our daily Bloomberg Law Brief,
- 0:02Speaker 1: exploring legal issues in the news, and today Bloomberg Lajo
- 0:05Speaker 1: stuon Grosso and Greg Store discuss an i r S
- 0:08Speaker 1: probe into the tax exempt status of a charity funded
- 0:12Speaker 1: by pharmaceutical companies. Critics say it allows pharmaceutical companies to
- 0:16Speaker 1: help patients pay for expensive drugs. They speak with Bloomberg
- 0:20Speaker 1: News reporter Robert Landgrath explain how these patient assistance charities work. So,
- 0:27Speaker 1: it turns out, if you're on Medicare, as a patient
- 0:30Speaker 1: on Medicare and other government programs, drug makers are not
- 0:33Speaker 1: allowed to directly pay for that patient's co payment if
- 0:38Speaker 1: they can't afford it. That's viewed at a potentially in
- 0:41Speaker 1: legal kickback. So it's happened as these a group of
- 0:45Speaker 1: charities that have sprung up to help patients can't afford it,
- 0:48Speaker 1: pay for their their portion their co payment of very
- 0:51Speaker 1: expensive drugs hundred thousand dollar drugs for cancer and multiple grosses.
- 0:56Speaker 1: And the controversy is over whether some of these charities
- 1:00Speaker 1: maybe too close in some way to their donors as
- 1:03Speaker 1: and it turns out they've created very narrow disease funds
- 1:06Speaker 1: where most of the money ends up going back UH
- 1:09Speaker 1: and these disease funds may be funded by just one
- 1:11Speaker 1: or two drug companies and most of the money ends
- 1:14Speaker 1: up going back to patients taking those drug companies drugs.
- 1:18Speaker 1: And now it turns out the I R S is
- 1:20Speaker 1: looking into one of these charities, the Chronic Disease Fund,
- 1:25Speaker 1: and looking to see whether, you know, does it deserve
- 1:28Speaker 1: tax except status? And the I R S has done
- 1:30Speaker 1: an analysis and as we found it in court papers
- 1:33Speaker 1: showing that of a nine point three million the charities
- 1:38Speaker 1: spent on co payment support in two thousand eleven went
- 1:40Speaker 1: back to patients taking drugs made by its donors. So
- 1:45Speaker 1: what is it that would be potentially illegal here? What
- 1:48Speaker 1: is the I r S looking for? Are those numbers
- 1:51Speaker 1: you're talking about enough to make a case or do
- 1:54Speaker 1: they have to find something more? Well, it's not clear
- 1:58Speaker 1: exactly what the I r S is going to, but
- 2:00Speaker 1: they do sometimes, you know, declare have findings that you know,
- 2:04Speaker 1: charity is no longer entitled to tax exempt status. We
- 2:08Speaker 1: talked to some tax experts who said, you know, what
- 2:10Speaker 1: the I R S appears to be looking at is
- 2:12Speaker 1: whether this charity was effectively really operating as a marketing
- 2:16Speaker 1: arm essentially of drug companies and therefore doesn't deserve its
- 2:20Speaker 1: charitable status and as Bloomberg News reporter Robert de Langreth
- 2:24Speaker 1: speaking with the Bloomberg lah Hoo stuon Grasso and Greg Sture.
- 2:27Speaker 1: You can listen to Bloomberg Law weekdays at one pm
- 2:29Speaker 1: Wall Street Time here on Bloomberg Radio, and that's this
- 2:32Speaker 1: morning's Bloomberg Law Brief. You can find more legal news
- 2:35Speaker 1: at Bloomberg Law dot com and Bloomberg b NA dot com.
- 2:39Speaker 1: Attorneys will find exceptional legal research and business development tools
- 2:42Speaker 1: there as well. Visit Bloomberg Law dot com and Bloomberg
- 2:46Speaker 1: b and A dot com for more information.